Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).

被引：5
|
作者：
Fogarty, Gerald
Dolven-Jacobsen, Kari
Morton, Rachael L.
Hruby, George
Nowak, Anna K.
Vardy, Janette L.
Drummond, Katharine J.
Dhillon, Haryana M.
Mandel, Catherine
Scolyer, Richard A.
Shivalingham, Brindha
Middleton, Mark R.
Burmeister, Bryan H.
Lo, Serigne
Reisse, Claudius H.
Paton, Elizabeth J.
Steel, Victoria
Williams, Narelle C.
Thompson, John F.
Hong, Angela M.
机构：
[1] Univ Technol, Mater Hosp, Melanoma Inst Australia, Genesis Care, Sydney, NSW, Australia
[2] Univ Technol, Univ Notre Dame, Australia & New Zealand Melanoma Trials Grp, Sydney, NSW, Australia
[3] Radium Hosp, Oslo Univ Hosp, Oslo, Norway
[4] Univ Sydney, NHMRC Clin Trials Ctr, Melanoma Inst Australia, Sydney, NSW, Australia
[5] Univ Sydney, Royal North Shore Hosp, Sydney Med Sch, Sydney, NSW, Australia
[6] Univ Western Australia, Sch Med, Perth, WA, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[8] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic, Australia
[9] Swinburne Univ Technol, Melbourne, Vic, Australia
[10] Univ Sydney, Royal Prince Alfred Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[11] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[12] Univ Oxford, Oxford, England
[13] Fraser Coast, Genesis Care, Hervey Bay, Qld, Australia
[14] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[15] Oslo Univ Hosp, Oslo, Norway
[16] Univ Sydney, Australia & New Zealand Melanoma Trials Grp, Sydney, NSW, Australia
[17] Royal Prince Alfred Hosp, Dept Melanoma & Surg Oncol, Melanoma Inst Australia, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9500
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1–3 brain metastases
    Bruno De Potter
    Gert De Meerleer
    Wilfried De Neve
    Tom Boterberg
    Bruno Speleers
    Piet Ost
    Neurological Sciences, 2013, 34 : 647 - 653
  • [32] Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study
    Mueller, R. P.
    Soffietti, R.
    Abaciouglu, M. U.
    Villa, S.
    Fauchon, F.
    Baumert, B. G.
    Fariselli, L.
    Tzuk-Shina, T.
    Collette, L.
    Kocher, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Adjuvant Whole Brain Radiotherapy vs. Observation after Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases - Results of the EORTC 22952-26001 Study
    Kocher, M.
    Mueller, R. P.
    Abacioglu, M. U.
    Villa, S.
    Fauchon, F.
    Baumert, B. G.
    Fariselli, L.
    Tzuk-Shina, T.
    Soffietti, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S5 - S5
  • [34] A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
    Morikawa, Aki
    Grkovski, Milan
    Patil, Sujata
    Jhaveri, Komal L.
    Tang, Kendrick
    Humm, John L.
    Holodny, Andrei
    Beal, Kathryn
    Schoder, Heiko
    Seidman, Andrew D.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (02) : 415 - 425
  • [35] ADJUVANT WHOLE BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES-RESULTS OF THE EORTC 22952-26001 STUDY
    Soffietti, Riccardo
    Mueller, Rolf-Peter
    Abacioglu, M. U.
    Villa, S.
    Fauchon, Francois
    Baumert, Brigitta
    Fariselli, Laura
    Tzuk-Shina, T.
    Collette, Laurence
    Kocher, Martin
    NEURO-ONCOLOGY, 2009, 11 (05) : 662 - 663
  • [36] A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
    Aki Morikawa
    Milan Grkovski
    Sujata Patil
    Komal L. Jhaveri
    Kendrick Tang
    John L. Humm
    Andrei Holodny
    Kathryn Beal
    Heiko Schöder
    Andrew D. Seidman
    Breast Cancer Research and Treatment, 2021, 188 : 415 - 425
  • [37] A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib.
    Morikawa, Aki
    Jhaveri, Komal L.
    Patil, Sujata
    Chen, Melanie
    McDonnell, Edward
    Neville, Deirdre A.
    Mak, Fung Ming
    Gansukh, Bolorsukh
    John, Humm L.
    Holodny, Andrei
    Schoeder, Hoiko
    Beal, Kathryn
    Seidman, Andrew David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
    Sperduto, Paul W.
    Shanley, Ryan
    Luo, Xianghua
    Andrews, David
    Werner-Wasik, Maria
    Valicenti, Richard
    Bahary, Jean-Paul
    Souhami, Luis
    Won, Minhee
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (03): : 526 - 531
  • [39] Feasibility study on protection of key organs in the whole brain radiotherapy with simultaneous integrated boost in patients with 1-3 brain metastases
    Yang, Y. W.
    Luo, H. Y.
    Chen, Y. Y.
    Zhang, J.
    Bai, X.
    Chen, M.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (01): : 83 - 89
  • [40] A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib
    Morikawa, A.
    Jhaveri, K.
    Grkovski, M.
    Tang, K.
    Humm, J. L.
    Holodny, A.
    Beal, K.
    Schoder, H.
    Seidman, A. D.
    CANCER RESEARCH, 2019, 79 (04)
12345